These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 417040)

  • 1. [Changes in tuberculosis].
    Freerksen E
    Internist (Berl); 1978 Mar; 19(3):156-60. PubMed ID: 417040
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the infectiousness of initially open pulmonary tuberculosis with reference to enforced isolation].
    Breu K
    Med Monatsschr; 1970 May; 24(5):198-201. PubMed ID: 4997660
    [No Abstract]   [Full Text] [Related]  

  • 3. [L forms of Mycobacterium tuberculosis and their clinico-epidemiological significance].
    Anastasatu C; Moldovan O
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(3):203-13. PubMed ID: 3001898
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isolation of bacteria from patients with pulmonary tuberculosis and chronic alcoholism].
    Rudoĭ NM; Chubakov TCh
    Probl Tuberk; 1984 Jul; (7):48-51. PubMed ID: 6435116
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects].
    Nitti V
    Arch Monaldi; 1972; 27(4):454-74. PubMed ID: 4217601
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study on the current incidence of bovine tuberculosis bacillus (Mycobacterium bovis) and on resistance to antitubercular antibiotics in human pulmonary tuberculosis].
    Viallier MJ
    J Med Lyon; 1968 Dec; 49(154):1857-86. PubMed ID: 4975074
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
    Korotaev GA; Kozulitsyna TI; Tret'iakova EA; Mamed'iarova FA
    Probl Tuberk; 1986; (7):32-6. PubMed ID: 3094001
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems of chronic excreters in pulmonary tuberculosis].
    Zhang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):170-3. PubMed ID: 2123419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dynamics of the appearance and persistence of elimination of mycobacteria and their significance (report)].
    Barbu Z; Bungetianu G; Bogdănescu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1976; 25(2):93-100. PubMed ID: 181831
    [No Abstract]   [Full Text] [Related]  

  • 11. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes and patterns of drug resistance of mycobacterium tuberculosis in patients with pulmonary tuberculosis (by data of the microbiological laboratory of research production association "Phthysiology")].
    Gorokhova TV
    Probl Tuberk; 1997; (2):33-5. PubMed ID: 9235582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the prevalence of drug-resistant tuberculosis from 1972 to 1982].
    Sasaki M; Oizumi K; Sato H; Watanabe A; Konno K
    Kekkaku; 1985 Apr; 60(4):241-5. PubMed ID: 3928959
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemoprevention of tuberculosis in children].
    Amann L
    Munch Med Wochenschr; 1973 Apr; 115(14):588-93. PubMed ID: 4541205
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs.
    Ann Pharmacother; 2006 May; 40(5):1007-8. PubMed ID: 16670365
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary drug resistance of Mycobacterium tuberculosis to antitubercular drugs and its clinical significance].
    Ianovskaia OM; Poliakova AN; Samuliak ID; Vasilik GV
    Probl Tuberk; 1975; (11):69-71. PubMed ID: 815904
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 19. [New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis].
    Skotnikova OI; Mikhaĭlovich VM; Nosova EIu; Lapa SA; Griadunov DA; Donnikov MIu; Badleeva MV; Galkina KIu; Dorozhkova IR; Litvinov VI; Zasedatelev AS; Moroz AM; Mirzabekov AD
    Probl Tuberk Bolezn Legk; 2004; (6):40-2. PubMed ID: 15315132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trends in the development of drug resistance in the causative agent of tuberculosis (based on data from an examination of hospital patients)].
    Priĭmak AA; Dolzhanskiĭ VM; Sagalovich VIa; El'murzaeva AA
    Probl Tuberk; 1985; (8):49-52. PubMed ID: 3932999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.